1. DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017) Authors: Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES. (June 2017) Authors: Cummin, T.E.; Araf, S.; Du, M.; Barrans, S.; Bentley, M.A.; Clipson, A.; Wang, M.; Ahmed, S.; Rahim, T.; Shah, C.; Hamid, D.; Dhondt, J.; Maishman, T.; Vaughan‐Spickers, N.; Pocock, C.; Forbes, A.; O'Callaghan, A.; Westhead, D.; Griffiths, G.O.; Fitzgibbon, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗